nodes	percent_of_prediction	percent_of_DWPC	metapath
Niflumic Acid—PLA2G4A—Epirubicin—uterine cancer	0.612	0.778	CbGbCtD
Niflumic Acid—PTGS2—Etoposide—uterine cancer	0.0946	0.12	CbGbCtD
Niflumic Acid—PTGS1—Etoposide—uterine cancer	0.0799	0.102	CbGbCtD
Niflumic Acid—CLCNKA—renal system—uterine cancer	0.0123	0.0776	CbGeAlD
Niflumic Acid—PLA2G1B—exocrine gland—uterine cancer	0.0121	0.076	CbGeAlD
Niflumic Acid—Mefenamic acid—AKR1C1—uterine cancer	0.00678	0.633	CrCbGaD
Niflumic Acid—SLC16A7—myometrium—uterine cancer	0.00563	0.0355	CbGeAlD
Niflumic Acid—PLA2G1B—epithelium—uterine cancer	0.00525	0.0331	CbGeAlD
Niflumic Acid—PTGS1—oviduct—uterine cancer	0.00502	0.0317	CbGeAlD
Niflumic Acid—PLA2G1B—renal system—uterine cancer	0.00487	0.0307	CbGeAlD
Niflumic Acid—UGT1A9—renal system—uterine cancer	0.00445	0.0281	CbGeAlD
Niflumic Acid—SLC16A7—uterine cervix—uterine cancer	0.00438	0.0276	CbGeAlD
Niflumic Acid—SLC16A7—decidua—uterine cancer	0.00417	0.0263	CbGeAlD
Niflumic Acid—PLA2G4A—myometrium—uterine cancer	0.00407	0.0257	CbGeAlD
Niflumic Acid—Mefenamic acid—AKR1C3—uterine cancer	0.00394	0.367	CrCbGaD
Niflumic Acid—PLA2G1B—female reproductive system—uterine cancer	0.0039	0.0246	CbGeAlD
Niflumic Acid—SLC16A7—mammalian vulva—uterine cancer	0.00383	0.0242	CbGeAlD
Niflumic Acid—SLC16A7—uterus—uterine cancer	0.00365	0.023	CbGeAlD
Niflumic Acid—PLA2G1B—female gonad—uterine cancer	0.00355	0.0224	CbGeAlD
Niflumic Acid—PTGS1—artery—uterine cancer	0.00333	0.021	CbGeAlD
Niflumic Acid—SLC16A7—female reproductive system—uterine cancer	0.00328	0.0207	CbGeAlD
Niflumic Acid—PTGS2—artery—uterine cancer	0.00318	0.0201	CbGeAlD
Niflumic Acid—PLA2G4A—uterine cervix—uterine cancer	0.00317	0.02	CbGeAlD
Niflumic Acid—PLA2G4A—smooth muscle tissue—uterine cancer	0.00308	0.0194	CbGeAlD
Niflumic Acid—PLA2G4A—decidua—uterine cancer	0.00302	0.019	CbGeAlD
Niflumic Acid—SLC16A7—vagina—uterine cancer	0.00297	0.0187	CbGeAlD
Niflumic Acid—PLA2G4A—renal system—uterine cancer	0.00296	0.0187	CbGeAlD
Niflumic Acid—PLA2G4A—endometrium—uterine cancer	0.00286	0.0181	CbGeAlD
Niflumic Acid—SLC16A1—epithelium—uterine cancer	0.00281	0.0177	CbGeAlD
Niflumic Acid—PLA2G4A—mammalian vulva—uterine cancer	0.00277	0.0175	CbGeAlD
Niflumic Acid—SLC16A1—decidua—uterine cancer	0.00266	0.0168	CbGeAlD
Niflumic Acid—SLC16A1—renal system—uterine cancer	0.00261	0.0165	CbGeAlD
Niflumic Acid—SLC16A1—endometrium—uterine cancer	0.00252	0.0159	CbGeAlD
Niflumic Acid—PLA2G4A—female reproductive system—uterine cancer	0.00237	0.015	CbGeAlD
Niflumic Acid—SLC16A1—uterus—uterine cancer	0.00232	0.0147	CbGeAlD
Niflumic Acid—PLA2G4A—female gonad—uterine cancer	0.00216	0.0136	CbGeAlD
Niflumic Acid—PLA2G4A—vagina—uterine cancer	0.00215	0.0135	CbGeAlD
Niflumic Acid—SLC16A1—female reproductive system—uterine cancer	0.00209	0.0132	CbGeAlD
Niflumic Acid—SLC16A7—lymph node—uterine cancer	0.00192	0.0121	CbGeAlD
Niflumic Acid—SLC16A1—female gonad—uterine cancer	0.0019	0.012	CbGeAlD
Niflumic Acid—PTGS2—myometrium—uterine cancer	0.00154	0.00969	CbGeAlD
Niflumic Acid—PLA2G4A—lymph node—uterine cancer	0.00139	0.00875	CbGeAlD
Niflumic Acid—PTGS1—epithelium—uterine cancer	0.00126	0.00796	CbGeAlD
Niflumic Acid—PTGS1—uterine cervix—uterine cancer	0.00125	0.00789	CbGeAlD
Niflumic Acid—SLC16A1—lymph node—uterine cancer	0.00122	0.00771	CbGeAlD
Niflumic Acid—PTGS1—smooth muscle tissue—uterine cancer	0.00122	0.00767	CbGeAlD
Niflumic Acid—PTGS2—epithelium—uterine cancer	0.00121	0.0076	CbGeAlD
Niflumic Acid—PTGS2—uterine cervix—uterine cancer	0.0012	0.00754	CbGeAlD
Niflumic Acid—PTGS1—renal system—uterine cancer	0.00117	0.00738	CbGeAlD
Niflumic Acid—PTGS2—smooth muscle tissue—uterine cancer	0.00116	0.00733	CbGeAlD
Niflumic Acid—PTGS1—endometrium—uterine cancer	0.00113	0.00713	CbGeAlD
Niflumic Acid—PTGS2—renal system—uterine cancer	0.00112	0.00705	CbGeAlD
Niflumic Acid—PTGS1—mammalian vulva—uterine cancer	0.00109	0.0069	CbGeAlD
Niflumic Acid—PTGS2—endometrium—uterine cancer	0.00108	0.00682	CbGeAlD
Niflumic Acid—PTGS1—uterus—uterine cancer	0.00104	0.00657	CbGeAlD
Niflumic Acid—PTGS2—uterus—uterine cancer	0.000997	0.00628	CbGeAlD
Niflumic Acid—PTGS1—female reproductive system—uterine cancer	0.000937	0.00591	CbGeAlD
Niflumic Acid—PTGS2—female reproductive system—uterine cancer	0.000896	0.00565	CbGeAlD
Niflumic Acid—PTGS1—female gonad—uterine cancer	0.000853	0.00538	CbGeAlD
Niflumic Acid—PTGS1—vagina—uterine cancer	0.000848	0.00534	CbGeAlD
Niflumic Acid—PTGS2—female gonad—uterine cancer	0.000815	0.00514	CbGeAlD
Niflumic Acid—PTGS2—vagina—uterine cancer	0.00081	0.00511	CbGeAlD
Niflumic Acid—PTGS1—lymph node—uterine cancer	0.000548	0.00346	CbGeAlD
Niflumic Acid—PTGS2—lymph node—uterine cancer	0.000524	0.0033	CbGeAlD
Niflumic Acid—PLA2G1B—Metabolism—DCN—uterine cancer	0.000115	0.00258	CbGpPWpGaD
Niflumic Acid—PLA2G4A—PDGFR-beta signaling pathway—PTEN—uterine cancer	0.000114	0.00257	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—CCL2—uterine cancer	0.000114	0.00257	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—IRF1—uterine cancer	0.000114	0.00257	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Endothelins—AKT1—uterine cancer	0.000114	0.00257	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—SRD5A2—uterine cancer	0.000114	0.00256	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—NDUFB11—uterine cancer	0.000114	0.00256	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000112	0.00253	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.00011	0.00249	CbGpPWpGaD
Niflumic Acid—PLA2G4A—AGE/RAGE pathway—AKT1—uterine cancer	0.00011	0.00247	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CYP11A1—uterine cancer	0.000108	0.00244	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—AKR1B1—uterine cancer	0.000106	0.00238	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—STAR—uterine cancer	0.000106	0.00238	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Phospholipid metabolism—PTEN—uterine cancer	0.000105	0.00238	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	0.000104	0.00236	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000104	0.00235	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000104	0.00235	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—CDKN2A—uterine cancer	0.000103	0.00233	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—AKR1C3—uterine cancer	0.000102	0.0023	CbGpPWpGaD
Niflumic Acid—PLA2G4A—PDGFR-beta signaling pathway—NRAS—uterine cancer	0.000102	0.0023	CbGpPWpGaD
Niflumic Acid—UGT1A9—PPARA activates gene expression—EP300—uterine cancer	9.98e-05	0.00225	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	9.88e-05	0.00223	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	9.88e-05	0.00223	CbGpPWpGaD
Niflumic Acid—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	9.77e-05	0.0022	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	9.53e-05	0.00215	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—SRD5A2—uterine cancer	9.41e-05	0.00212	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—NDUFB11—uterine cancer	9.41e-05	0.00212	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	9.34e-05	0.00211	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	9.14e-05	0.00206	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	9.14e-05	0.00206	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—CDKN1B—uterine cancer	9.13e-05	0.00206	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—CCL2—uterine cancer	9.01e-05	0.00203	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	8.88e-05	0.002	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	8.82e-05	0.00199	CbGpPWpGaD
Niflumic Acid—PLA2G4A—PDGFR-beta signaling pathway—KRAS—uterine cancer	8.76e-05	0.00198	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	8.63e-05	0.00195	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	8.33e-05	0.00188	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—POLD1—uterine cancer	8.28e-05	0.00187	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—STAR—uterine cancer	8.21e-05	0.00185	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—AKR1B1—uterine cancer	8.21e-05	0.00185	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	8.12e-05	0.00183	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	8.11e-05	0.00183	CbGpPWpGaD
Niflumic Acid—PLA2G4A—PDGFR-beta signaling pathway—PIK3CA—uterine cancer	8.04e-05	0.00181	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—EP300—uterine cancer	8.01e-05	0.00181	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—STK11—uterine cancer	7.94e-05	0.00179	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CYP19A1—uterine cancer	7.94e-05	0.00179	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—AKR1C1—uterine cancer	7.75e-05	0.00175	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	7.75e-05	0.00175	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NDUFB11—uterine cancer	7.67e-05	0.00173	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—SRD5A2—uterine cancer	7.67e-05	0.00173	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—NRAS—uterine cancer	7.5e-05	0.00169	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.45e-05	0.00168	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	7.45e-05	0.00168	CbGpPWpGaD
Niflumic Acid—PLA2G4A—PDGFR-beta signaling pathway—HRAS—uterine cancer	7.44e-05	0.00168	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Phospholipid metabolism—PIK3CA—uterine cancer	7.43e-05	0.00168	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AKR1B10—uterine cancer	7.38e-05	0.00167	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	7.34e-05	0.00166	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	7.25e-05	0.00164	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—CXCL8—uterine cancer	7.12e-05	0.00161	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.11e-05	0.0016	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	7.04e-05	0.00159	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	6.96e-05	0.00157	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—CDKN1B—uterine cancer	6.95e-05	0.00157	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—RRM2—uterine cancer	6.91e-05	0.00156	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—STAR—uterine cancer	6.8e-05	0.00153	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—AKR1B1—uterine cancer	6.8e-05	0.00153	CbGpPWpGaD
Niflumic Acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	6.73e-05	0.00152	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.72e-05	0.00152	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—DCN—uterine cancer	6.7e-05	0.00151	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	6.53e-05	0.00147	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—KRAS—uterine cancer	6.45e-05	0.00146	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—POLD1—uterine cancer	6.44e-05	0.00145	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CYP11A1—uterine cancer	6.32e-05	0.00142	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	6.24e-05	0.00141	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RNF43—uterine cancer	6.12e-05	0.00138	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SRD5A2—uterine cancer	6.09e-05	0.00137	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NDUFB11—uterine cancer	6.09e-05	0.00137	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—AKR1C1—uterine cancer	6.02e-05	0.00136	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—MTHFR—uterine cancer	5.97e-05	0.00135	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—AKR1C3—uterine cancer	5.96e-05	0.00135	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.91e-05	0.00133	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	5.73e-05	0.00129	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—AKR1B10—uterine cancer	5.65e-05	0.00128	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—INHBA—uterine cancer	5.6e-05	0.00126	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.58e-05	0.00126	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—STAR—uterine cancer	5.54e-05	0.00125	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—AKR1B1—uterine cancer	5.54e-05	0.00125	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	5.54e-05	0.00125	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—HRAS—uterine cancer	5.48e-05	0.00124	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.48e-05	0.00124	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—RRM2—uterine cancer	5.37e-05	0.00121	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—POLD1—uterine cancer	5.34e-05	0.0012	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.26e-05	0.00119	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—DCN—uterine cancer	5.21e-05	0.00118	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	5.11e-05	0.00115	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	5.1e-05	0.00115	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AKR1C1—uterine cancer	5.04e-05	0.00114	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—AKR1C1—uterine cancer	4.99e-05	0.00113	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CYP11A1—uterine cancer	4.91e-05	0.00111	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	4.73e-05	0.00107	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—RNF43—uterine cancer	4.68e-05	0.00106	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	4.68e-05	0.00106	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—STK11—uterine cancer	4.65e-05	0.00105	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CYP19A1—uterine cancer	4.65e-05	0.00105	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—AKR1C3—uterine cancer	4.64e-05	0.00105	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—EP300—uterine cancer	4.57e-05	0.00103	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	4.47e-05	0.00101	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—RRM2—uterine cancer	4.45e-05	0.001	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—STAR—uterine cancer	4.4e-05	0.000993	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—AKR1B1—uterine cancer	4.4e-05	0.000993	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TP53—uterine cancer	4.37e-05	0.000986	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	4.36e-05	0.000983	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—POLD1—uterine cancer	4.35e-05	0.000982	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.35e-05	0.000982	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—VEGFA—uterine cancer	4.33e-05	0.000976	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—DCN—uterine cancer	4.32e-05	0.000975	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—NRAS—uterine cancer	4.27e-05	0.000964	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—uterine cancer	4.17e-05	0.00094	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	4.15e-05	0.000937	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYP11A1—uterine cancer	4.07e-05	0.000918	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—AKR1C1—uterine cancer	4.07e-05	0.000918	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	3.93e-05	0.000888	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AKR1C3—uterine cancer	3.88e-05	0.000875	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—AKR1C1—uterine cancer	3.86e-05	0.00087	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—AKR1C3—uterine cancer	3.84e-05	0.000867	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PGR—uterine cancer	3.78e-05	0.000853	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—KRAS—uterine cancer	3.68e-05	0.00083	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—RRM2—uterine cancer	3.63e-05	0.000818	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—STK11—uterine cancer	3.61e-05	0.000815	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CYP19A1—uterine cancer	3.61e-05	0.000815	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—YWHAE—uterine cancer	3.61e-05	0.000814	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—EP300—uterine cancer	3.55e-05	0.000802	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—DCN—uterine cancer	3.52e-05	0.000795	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—MTHFR—uterine cancer	3.49e-05	0.000788	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—FBXW7—uterine cancer	3.46e-05	0.00078	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—POLD1—uterine cancer	3.45e-05	0.000779	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.39e-05	0.000765	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—PIK3CA—uterine cancer	3.38e-05	0.000763	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—VEGFA—uterine cancer	3.37e-05	0.000759	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	3.34e-05	0.000755	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—DCN—uterine cancer	3.34e-05	0.000753	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—NRAS—uterine cancer	3.32e-05	0.00075	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PTEN—uterine cancer	3.32e-05	0.000749	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP11A1—uterine cancer	3.32e-05	0.000749	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—TP53—uterine cancer	3.27e-05	0.000738	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.23e-05	0.00073	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—AKR1C1—uterine cancer	3.23e-05	0.000729	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—EP300—uterine cancer	3.17e-05	0.000714	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—AKR1C3—uterine cancer	3.13e-05	0.000707	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—HRAS—uterine cancer	3.13e-05	0.000706	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	3.07e-05	0.000693	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—STK11—uterine cancer	3.02e-05	0.000682	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CCL2—uterine cancer	3.01e-05	0.000679	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYP19A1—uterine cancer	2.99e-05	0.000676	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—STK11—uterine cancer	2.99e-05	0.000676	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.97e-05	0.000671	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—AKR1C3—uterine cancer	2.97e-05	0.00067	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HMGA1—uterine cancer	2.89e-05	0.000653	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—RRM2—uterine cancer	2.88e-05	0.00065	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—KRAS—uterine cancer	2.86e-05	0.000645	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SOCS3—uterine cancer	2.83e-05	0.000638	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.81e-05	0.000634	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—DCN—uterine cancer	2.8e-05	0.000631	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—AKT1—uterine cancer	2.76e-05	0.000623	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—MTHFR—uterine cancer	2.72e-05	0.000613	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CDKN2B—uterine cancer	2.71e-05	0.000611	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.68e-05	0.000605	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—FBXW7—uterine cancer	2.65e-05	0.000597	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP11A1—uterine cancer	2.63e-05	0.000594	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IGF1R—uterine cancer	2.63e-05	0.000593	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—PIK3CA—uterine cancer	2.63e-05	0.000593	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TP53—uterine cancer	2.54e-05	0.000574	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.51e-05	0.000566	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—AKR1C3—uterine cancer	2.49e-05	0.000561	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SMAD3—uterine cancer	2.47e-05	0.000558	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—STK11—uterine cancer	2.44e-05	0.000551	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP19A1—uterine cancer	2.44e-05	0.000551	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—HRAS—uterine cancer	2.43e-05	0.000549	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.39e-05	0.00054	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CXCL8—uterine cancer	2.38e-05	0.000537	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—FGFR2—uterine cancer	2.36e-05	0.000532	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PIK3CA—uterine cancer	2.34e-05	0.000528	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.29e-05	0.000517	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—MTHFR—uterine cancer	2.25e-05	0.000508	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.19e-05	0.000493	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—AKT1—uterine cancer	2.15e-05	0.000484	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CDKN2B—uterine cancer	2.07e-05	0.000468	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ESR1—uterine cancer	2.02e-05	0.000455	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.98e-05	0.000447	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PTEN—uterine cancer	1.94e-05	0.000438	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—STK11—uterine cancer	1.94e-05	0.000437	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP19A1—uterine cancer	1.94e-05	0.000437	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—AKT1—uterine cancer	1.91e-05	0.000432	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—NRAS—uterine cancer	1.91e-05	0.00043	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SMAD3—uterine cancer	1.89e-05	0.000427	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—EP300—uterine cancer	1.85e-05	0.000418	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—MTHFR—uterine cancer	1.83e-05	0.000414	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.82e-05	0.00041	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—FGFR2—uterine cancer	1.81e-05	0.000408	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCL2—uterine cancer	1.78e-05	0.000401	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MTHFR—uterine cancer	1.74e-05	0.000392	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.73e-05	0.000391	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—KRAS—uterine cancer	1.64e-05	0.00037	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.62e-05	0.000365	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PTEN—uterine cancer	1.51e-05	0.000341	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—PIK3CA—uterine cancer	1.51e-05	0.00034	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ERBB2—uterine cancer	1.48e-05	0.000334	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MTHFR—uterine cancer	1.46e-05	0.000329	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—EP300—uterine cancer	1.44e-05	0.000325	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CXCL8—uterine cancer	1.4e-05	0.000317	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HRAS—uterine cancer	1.4e-05	0.000315	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CDKN1B—uterine cancer	1.37e-05	0.00031	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PIK3CA—uterine cancer	1.37e-05	0.000309	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CTNNB1—uterine cancer	1.3e-05	0.000292	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.28e-05	0.00029	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PTEN—uterine cancer	1.26e-05	0.000285	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTEN—uterine cancer	1.25e-05	0.000282	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—AKT1—uterine cancer	1.23e-05	0.000278	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EP300—uterine cancer	1.2e-05	0.000272	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—EP300—uterine cancer	1.19e-05	0.000269	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—VEGFA—uterine cancer	1.14e-05	0.000257	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ERBB2—uterine cancer	1.13e-05	0.000256	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NRAS—uterine cancer	1.13e-05	0.000254	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—AKT1—uterine cancer	1.12e-05	0.000253	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PIK3CA—uterine cancer	1.07e-05	0.00024	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CDKN1B—uterine cancer	1.05e-05	0.000237	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PTEN—uterine cancer	1.02e-05	0.00023	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CTNNB1—uterine cancer	9.92e-06	0.000224	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—EP300—uterine cancer	9.73e-06	0.00022	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—KRAS—uterine cancer	9.7e-06	0.000219	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PTEN—uterine cancer	9.67e-06	0.000218	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—EP300—uterine cancer	9.22e-06	0.000208	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PIK3CA—uterine cancer	8.91e-06	0.000201	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PIK3CA—uterine cancer	8.83e-06	0.000199	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—AKT1—uterine cancer	8.71e-06	0.000196	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NRAS—uterine cancer	8.63e-06	0.000195	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TP53—uterine cancer	8.62e-06	0.000194	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HRAS—uterine cancer	8.24e-06	0.000186	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PTEN—uterine cancer	8.1e-06	0.000183	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—EP300—uterine cancer	7.73e-06	0.000174	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—KRAS—uterine cancer	7.43e-06	0.000168	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AKT1—uterine cancer	7.28e-06	0.000164	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—AKT1—uterine cancer	7.21e-06	0.000163	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PIK3CA—uterine cancer	7.2e-06	0.000162	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PIK3CA—uterine cancer	6.82e-06	0.000154	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HRAS—uterine cancer	6.31e-06	0.000142	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—AKT1—uterine cancer	5.88e-06	0.000133	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PIK3CA—uterine cancer	5.71e-06	0.000129	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—AKT1—uterine cancer	5.57e-06	0.000126	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—AKT1—uterine cancer	4.67e-06	0.000105	CbGpPWpGaD
